![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
![[thumbnail of 14496oa.pdf]](https://mdc-test.eprints-hosting.org/style/images/fileicons/application_pdf.png) |
PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Article |
|---|---|
| Title: | Clinical lessons to be learned from patients developing chronic myeloid leukemia while on immunosuppressive therapy after solid organ transplantation: yet another dase after orthotopic heart transplantation |
| Creators Name: | Oberender, C., Kleeberg, L., Nienhues, N., Gresse, M., Doerken, B., Riess, H. and le Coutre, P. |
| Abstract: | Chronic myeloid leukemia developing after transplantation of solid organs and concomitant immunosuppression is a rare but still significant clinical phenomenon. We here describe an additional case of a 62-year-old male patient developing CML after orthotopic heart transplantation and medication with cyclosporine A, mofetil-mycophenolate, and steroids. Initial antileukemic therapy was imatinib at a standard dose and within 15 months of therapy a complete cytogenetic response was noted. In this report we discuss the clinical implications of these rare but biologically important cases. |
| Source: | Case Reports in Hematology |
| ISSN: | 2090-6579 |
| Publisher: | Hindawi |
| Volume: | 2014 |
| Page Range: | 890438 |
| Date: | 16 November 2014 |
| Official Publication: | https://doi.org/10.1155/2014/890438 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
